BDBM123057 US8742134, (4)::US8742134, (5)::US8742134, (6)
SMILES: C[N+]1(C)C2CCC1[C@H](C2)OC(=O)[C@@](O)(C1CCCC1)c1ccccc1
InChI Key: InChIKey=GIQCKBPBJOZAKR-XSNSTOHYSA-N
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Muscarinic acetylcholine receptor M3 (Homo sapiens (Human)) | BDBM123057 (US8742134, (4) | US8742134, (5) | US8742134, (6)) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 0.220 | -13.0 | 0.300 | n/a | n/a | n/a | n/a | n/a | 22 |
Theron Pharmaceuticals, Inc. US Patent | Assay Description Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). ... | US Patent US8742134 (2014) BindingDB Entry DOI: 10.7270/Q20000SX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M3 (Homo sapiens (Human)) | BDBM123057 (US8742134, (4) | US8742134, (5) | US8742134, (6)) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 1.5 | -11.9 | 2.10 | n/a | n/a | n/a | n/a | n/a | 22 |
Theron Pharmaceuticals, Inc. US Patent | Assay Description Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). ... | US Patent US8742134 (2014) BindingDB Entry DOI: 10.7270/Q20000SX | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Muscarinic acetylcholine receptor M3 (Homo sapiens (Human)) | BDBM123057 (US8742134, (4) | US8742134, (5) | US8742134, (6)) | Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | 2.10 | -11.7 | 2.90 | n/a | n/a | n/a | n/a | n/a | 22 |
Theron Pharmaceuticals, Inc. US Patent | Assay Description Radioligand binding studies were carried out with M3 receptor cell homogenates as described (Peralta et al., The EMBO Journal 6, 3923-3929, (1987)). ... | US Patent US8742134 (2014) BindingDB Entry DOI: 10.7270/Q20000SX | |||||||||||
More data for this Ligand-Target Pair |